Alcyone MEMS Cannula

The US Food and Drug Administration (FDA) has granted clearance for Alcyone Lifesciences’ Alcyone MEMS Cannula (AMC), a neuro-ventricular cannula.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The AMC is a dual-lumen, MRI-compatible injection and aspiration cannula, designed for use in the brain.

The company said the AMC is not intended for implant and was developed for single patient use only.

"The AMC is a dual-lumen, MRI-compatible injection and aspiration cannula, designed for use in the brain."

Alcyone Lifesciences founder PJ Anand said: "The neuroscience community is pioneering new therapeutic agents including gene therapy, antibody and oncolytic biologic therapy that hold great promise in treating chronic CNS disorders, but unfortunately they have lacked a clinically effective technology for precise CNS delivery direct to a neurological target and for optimal bio-distribution.

"Given that the very potential of these new agents is dependent on optimal bio-distribution, it is our hope that the AMC will offer a solution for this critical unmet clinical need and further open the gates to novel therapeutic options for patients."

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Developed using the company’s microelectromechanical system (MEMS) platform, the AMC can be used with any existing commercial imaging and stereotactic system.

Alcyone director of Product Development Deep Singh said: "Neurosurgeons can select a target, navigate the AMC precisely to the target, and observe in real-time the precision delivery of the therapeutic agent, all under intra-procedural MRI guidance."

Apart from the MEMS tip which has dual micro-channels, the AMC features a patented distal end design that helps prevent reflux or back flow along the cannula shaft, which can be a significant drawback with current devices.

Image: Alcyone MEMS Cannula. Photo: courtesy of Business Wire / Alcyone Lifesciences Inc.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact